Search - tctmd.com

Displaying 1 - 20 of 21

Sort: Relevancy | Date

Presentation TCT 2017

Bioresorbable Scaffolds and Stents: From PROSPECT-ABSORB to PREVENT (With Case Examples)

Presenter: Gregg W. Stone, Peter H. Stone, Jung-Min Ahn

November 01, 2017

Presentation TCT 2017

Keynote Lecture: Personalized Treatment of the Vulnerable Patient With PCSK9 Inhibitors, Anti-inflammatory Therapies and CTEP Inhibitors

Presenter: Gregg W. Stone, Peter H. Stone, Evan A. Stein

November 01, 2017

Presentation TCT 2017

Novel Invasive Diagnostics IV: Molecular Imaging

Presenter: Ik-Kyung Jang, Yoshinobu Onuma, Farouc Jaffer

November 01, 2017

Presentation TCT 2017

Novel Invasive Diagnostics III: Shear Stress Approaches (Endothelial, Wall, Plaque)

Presenter: Ik-Kyung Jang, Yoshinobu Onuma, Habib Samady

November 01, 2017

Presentation TCT 2017

PET-CT: Atherosclerosis and Perfusion

Presenter: Pamela S. Douglas, Jonathon A. Leipsic, James K. Min, Paul Knaapen

November 01, 2017

Presentation TCT 2017

Novel Invasive Diagnostics II: NIRS-Based

Presenter: Ik-Kyung Jang, Yoshinobu Onuma, David Erlinge

November 01, 2017

Presentation TCT 2017

Novel Invasive Diagnostics I: OCT-Derived Imaging

Presenter: Ik-Kyung Jang, Yoshinobu Onuma, Akiko Maehara

November 01, 2017

Presentation TCT 2017

Novel Noninvasive Approaches II: NaF PET

Presenter: Ik-Kyung Jang, Yoshinobu Onuma, Bon-Kwon Koo

November 01, 2017

Presentation TCT 2017

Novel Noninvasive Approaches I: CT-Based

Presenter: Ik-Kyung Jang, Yoshinobu Onuma, James K. Min

November 01, 2017

Presentation TCT 2017

Current State-of-the-Art: Identification of Vulnerable Patients and Plaques in Patients Undergoing Coronary Angiography

Presenter: John A. Ambrose, Y. S. Chandrashekhar, Akiko Maehara

November 01, 2017

Presentation TCT 2017

Current State-of-the-Art: Identification of Vulnerable Patients and Plaques With Noninvasive Testing

Presenter: John A. Ambrose, Y. S. Chandrashekhar, James A. Goldstein

November 01, 2017

Presentation TCT 2017

Worldwide Deaths and MI From Coronary Atherosclerosis: Scope of an Epidemic

Presenter: John A. Ambrose, Y. S. Chandrashekhar, James E. Muller

November 01, 2017

Presentation TCT 2017

Potential Interventions for Hypertensive Patients With HFpEF

Presenter: Mark C. Bates, Bernard J. Gersh, William T. Abraham

October 30, 2017

Presentation TCT 2017

Does Left Ventricular Hypertrophy Compromise Coronary Flow Reserve and Affect Intervention Choices?

Presenter: Mark C. Bates, Bernard J. Gersh, Justin E. Davies

October 30, 2017

Presentation TCT 2017

When Should Coronary Disease Be Suspected and Worked Up in Hypertension?

Presenter: Mark C. Bates, Bernard J. Gersh, Farrell O. Mendelsohn

October 30, 2017

Presentation TCT 2017

Why Are Hypertension and Coronary Artery Disease So Connected?

Presenter: Mark C. Bates, Bernard J. Gersh, Suzanne Oparil

October 30, 2017

Presentation TCT 2017

Renal Artery Atherosclerosis and Secondary Hypertension: Frequency, Diagnosis, and Treatment

Presenter: Mark C. Bates, Bernard J. Gersh, Michael R. Jaff

October 30, 2017

Presentation CDM 2017

Transitiong From a CAD to Peripheral Vascular Disease Practice

Presenter: Terry R. Bowers

October 05, 2017

Early versus Late Revascularization in Patients Hospitalized with Non ST-Segment Elevation Myocardial Infarction: The Atherosclerosis Risk in Communities (ARIC) Surveillance Study

Presentation SCAI 2017

The Atherosclerosis Risk in Communities (ARIC) Surveillance Study

Presenter: Sameer Arora

May 13, 2017

Presentation ACC 2017

Results of the CARAT Study: Effect of Serial Infusions of CER-001, a Pre-Beta High-Density Lipoprotein Mimetic on Coronary Atherosclerosis

Presenter: Stephen J Nicholls

March 20, 2017

Advertisement

Bioresorbable Scaffolds and Stents: From PROSPECT-ABSORB to PREVENT (With Case Examples)

Keynote Lecture: Personalized Treatment of the Vulnerable Patient With PCSK9 Inhibitors, Anti-inflammatory Therapies and CTEP Inhibitors

Novel Invasive Diagnostics IV: Molecular Imaging

Novel Invasive Diagnostics III: Shear Stress Approaches (Endothelial, Wall, Plaque)

PET-CT: Atherosclerosis and Perfusion

Novel Invasive Diagnostics II: NIRS-Based

Novel Invasive Diagnostics I: OCT-Derived Imaging

Novel Noninvasive Approaches II: NaF PET

Novel Noninvasive Approaches I: CT-Based

Current State-of-the-Art: Identification of Vulnerable Patients and Plaques in Patients Undergoing Coronary Angiography

Current State-of-the-Art: Identification of Vulnerable Patients and Plaques With Noninvasive Testing

Worldwide Deaths and MI From Coronary Atherosclerosis: Scope of an Epidemic

Potential Interventions for Hypertensive Patients With HFpEF

Does Left Ventricular Hypertrophy Compromise Coronary Flow Reserve and Affect Intervention Choices?

When Should Coronary Disease Be Suspected and Worked Up in Hypertension?

Why Are Hypertension and Coronary Artery Disease So Connected?

Renal Artery Atherosclerosis and Secondary Hypertension: Frequency, Diagnosis, and Treatment

Transitiong From a CAD to Peripheral Vascular Disease Practice

The Atherosclerosis Risk in Communities (ARIC) Surveillance Study

Results of the CARAT Study: Effect of Serial Infusions of CER-001, a Pre-Beta High-Density Lipoprotein Mimetic on Coronary Atherosclerosis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content